Primary Cell Culture Market Thrives: Detailed Analysis Highlights Market Size, Emerging Trends, Growth Factors, and Competitive Insights Shaping Future Demand

The new report published by The Business Research Company, titled "Primary Cell Culture Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the primary cell culture market size has grown rapidly in recent years. It will grow from $5.91 billion in 2023 to $6.79 billion in 2024 at a compound annual growth rate (CAGR) of 14.9%. The primary cell culture market size is expected to see rapid growth in the next few years. It will grow to $11.89 billion in 2028 at a compound annual growth rate (CAGR) of 15%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15903&type=smp

Rising Prevalence Of Chronic Diseases Fuels Growth In Primary Cell Culture Market
The increasing prevalence of chronic diseases is expected to propel the growth of the primary cell culture market going forward. Chronic diseases are long-lasting conditions that typically progress slowly and persist for long, often for the remainder of an individual's life. The rise in chronic diseases can be attributed to various factors, including lifestyle changes, environmental influences, physical inactivity, dietary shifts, and demographic shifts. Primary cell cultures significantly advance knowledge and treatment strategies for chronic diseases, ultimately improving patient outcomes. For instance, in January 2023, according to the National Center For Biotechnology Information, a US-based government agency, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the increasing prevalence of chronic diseases drives the primary cell culture market.

Development Of Cost-Effective Cell Banks To Boost Cultivated Meat Research And Innovation
Major companies operating in the primary cell culture market are developing cell banks that contain primary cells specifically for cultivated meat research, aiming to advance sustainable and ethical meat production technologies. The Cell Bank initiative aims to support early-stage companies and researchers by providing high-quality animal primary cells suitable for cultivated meat research and development, up to 90% cheaper than other cell line providers, and free from licensing restrictions. For instance, in June 2023, Extracellular, a UK-based CDMO (contract development and manufacturing organization), launched low-cost, license-free cell banks to support the cultivated meat sector. The cell banks initially offer cells isolated from cows, pigs, and lambs' fat, muscle, and bone marrow tissues. This project demonstrates a collaborative approach to accelerate the growth of the cultivated meat industry in the UK by increasing the availability of cell lines and enabling researchers and companies to develop innovative technologies without restrictions from licensing or commercial agreements.

The primary cell culture market covered in this report is segmented -

1) By Product: Primary Cell, Reagents, Supplements, Media
2) By Cell Type: Animal Cells, Human Cells
3) By Separation And culture Techniques: Explant Method, Enzymatic Disaggregation, Mechanical Separation, Other Separation
4) By Application: Tissue Culture and Tissue Engineering, Vaccine Production, Gene Therapy And Regenerative Medicine, Drug Screening And Toxicity Testing, Cancer Research , Virology, Strem Cell Therapy, Other Applications
5) By End User: Pharmaceutical And Biotechnology Company And Contract Research Organizations, Academic And Research Institutes, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15903&type=discount

Major companies operating in the primary cell culture market are Thermo Fisher Scientific Inc., Merck KGaA , FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec and CO.KG, STEMCELL Technologies Inc., Cyagen Biosciences Inc., Hi Media Laboratories Pvt. Ltd., PromoCell GmbH, AllCells LLC, BPS Bioscience Inc., MatTek Ltd., Axol Bioscience Ltd., Lifeline Cell Technology Corp., Neuromics Inc., Cell Biologics Inc., ZenBio Inc., Epithelix Sàrl, ReachBio LLC, AcceGen Biotechnology, Biopredic International, ixCells Biotechnologies

Contents of the report:
1. Executive Summary
2. Primary Cell Culture Market Report Structure
3. Primary Cell Culture Market Trends And Strategies
4. Primary Cell Culture Market - Macro Economic Scenario
5. Primary Cell Culture Market Size And Growth
…..
27. Primary Cell Culture Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/primary-cell-culture-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.